FDA Clearance Tracker · P980003
CHILLI COOLED RF ABLATION SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 2, 1999 (this decision)Source: openFDAMethods & limitations
Decided
Feb 2, 1999
Approval withdrawn
Time to decision
368 days
Received Jan 30, 1998. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P980003
- Device name
- CHILLI COOLED RF ABLATION SYSTEM
- Applicant
- Boston Scientific Corp
- Applicant location
- San Jose, CA
- Received
- Jan 30, 1998
- Decided
- Feb 2, 1999
- Decision
- Approval withdrawn
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Supplements
- 90 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Cardiac ablation percutaneous catheter (LPB)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Chili(R) Cooled Ablation System which includes: 1)Chili(R) Cooled Ablation Catheter, Standard Curve (Model 3005; 2)Chili(R) Cooled Ablation Catheter, Large Curve (Model 3006); RF Generator/Pump System (Model 8004); EGM Bypass Switch Box (model 2035); RF Filter Box (Model 2048); Chili(R) Tubing Kit (Model 2100); EGM/RF Generator Cable (Models 2001 and 2028); and EGM Generator Cable (Model 2002 and 2029). This device is indicated for cardiac electropysiological mapping, delivering diagnostic pacing stimuli, and radiofrequency ablation of mappable ventricular tachycardias attributable to ischemic heart disease or cardiomyopathy in patients who have failed drug therapy.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LPB. The earliest in FDA's data is P920047, decided Oct 28, 1994.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
- WATCHMAN FLX Left Atrial Appendage (LAA) Closure Technology, WATCHMAN FLX Left Atrial Appendage Closure Device with DeliPMA supplement
P130013-S074 · Decided Jul 16, 2025 · 180 days after receipt · Panel Track
Device type: System, appendage closure, left atrial (NGV) · Cardiology
K243245 · Decided Oct 18, 2024 · 7 days after receipt
Device type: Unit, Cryosurgical, Accessories (GEH) · General & Plastic Surgery
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.